CADL CANDEL THERAPEUTICS INC
Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · estimated
What 14 analyst firms say about CANDEL THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
13 rated views · 14 analyst/firm records · 14 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8065
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8039
Recent analyst activity · last 90 days
Our tracked history has 8 reports on CADL from 6 analyst firms in the last 90 days (14 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 1 left it unchanged and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: BofA Securities raised its target from $12.00 (set 14 Aug 2026) to $18.00 on 21 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Alec Stranahan | Buy | 21 Sep 2026 | 18.00 USD |
| Brookline Capital Markets | Kemp Dolliver | Buy | 17 May 2026 | 29.00 USD |
| Canaccord Genuity | John Newman | Buy | 13 Mar 2026 | 25.00 USD |
| Cantor Fitzgerald | Imogen Mansfield | Buy | 20 Apr 2026 | — |
| Citigroup | Yigal Nochomovitz | Buy | 13 Mar 2026 | Conflicting reports · excluded |
| Freedom Capital Markets | Ilya Zubkov | Buy | 1 Jul 2026 | 15.00 USD |
| H.C. Wainwright | Andres Y. Maldonado | Buy | 2 Oct 2026 | 23.00 USD · 29 Jul 2026 |
| Jefferies | Maury Raycroft | Buy | 22 Oct 2026 | 25.00 USD |
| Lifesci Capital | Oliver Mccammon | Buy | 12 Mar 2026 | 16.00 USD |
| Stephens | Sudan Loganathan | Buy | 8 Dec 2025 | 15.00 USD |
| Stifel | Stephen Willey | Buy | 13 Jul 2026 | 22.00 USD |
| UBS | Unnamed analyst | Buy | 17 Aug 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Sell | 14 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.